Orally effective iron chelators for the treatment of iron overload disease: the case for a further look at pyridoxal isonicotinoyl hydrazone and its analogs.
Richardson
D R
DR
Ponka
P
P
D000284:Administration, Oral; D000818:Animals; D000077543:Deferiprone; D005293:Ferritins / Q000378:metabolism; D007501:Iron / Q000378:metabolism; D007502:Iron Chelating Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D019190:Iron Overload / Q000188:drug therapy*; D007538:Isoniazid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011728:Pyridones / Q000627:therapeutic use; D011730:Pyridoxal / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D051381:Rats; D016896:Treatment Outcome
D007502:Iron Chelating Agents; D011728:Pyridones; D000077543:Deferiprone; D011730:Pyridoxal; C021079:pyridoxal isonicotinoyl hydrazone; D005293:Ferritins; D007501:Iron; D007538:Isoniazid